Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$165.67 - $199.94 $16,235 - $19,594
-98 Reduced 6.01%
1,533 $259,000
Q2 2023

Aug 07, 2023

SELL
$160.94 - $186.23 $328,156 - $379,722
-2,039 Reduced 55.56%
1,631 $280,000
Q1 2023

May 10, 2023

SELL
$145.48 - $175.02 $19,785 - $23,802
-136 Reduced 3.57%
3,670 $610,000
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $262 - $314
2 Added 0.05%
3,806 $557,000
Q3 2022

Oct 27, 2022

SELL
$148.29 - $182.55 $44,931 - $55,312
-303 Reduced 7.38%
3,804 $564,000
Q2 2022

Jul 28, 2022

SELL
$155.97 - $200.09 $154,878 - $198,689
-993 Reduced 19.47%
4,107 $705,000
Q1 2022

Apr 28, 2022

BUY
$181.39 - $234.03 $175,404 - $226,307
967 Added 23.4%
5,100 $961,000
Q4 2021

Feb 07, 2022

BUY
$193.69 - $247.03 $226,229 - $288,531
1,168 Added 39.39%
4,133 $1.01 Million
Q3 2021

Oct 28, 2021

SELL
$189.29 - $209.69 $757 - $838
-4 Reduced 0.13%
2,965 $575,000
Q2 2021

Aug 11, 2021

SELL
$155.9 - $187.99 $84,341 - $101,702
-541 Reduced 15.41%
2,969 $553,000
Q1 2021

May 10, 2021

BUY
$144.0 - $169.39 $146,160 - $171,930
1,015 Added 40.68%
3,510 $552,000
Q4 2020

Jan 25, 2021

BUY
$157.07 - $174.35 $47,906 - $53,176
305 Added 13.93%
2,495 $412,000
Q3 2020

Nov 04, 2020

BUY
$137.1 - $165.37 $9,322 - $11,245
68 Added 3.2%
2,190 $362,000
Q2 2020

Aug 07, 2020

SELL
$111.92 - $142.53 $6,267 - $7,981
-56 Reduced 2.57%
2,122 $290,000
Q1 2020

May 05, 2020

SELL
$92.66 - $144.94 $1,297 - $2,029
-14 Reduced 0.64%
2,178 $256,000
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $15,577 - $17,855
-134 Reduced 5.76%
2,192 $290,000
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $7,879 - $8,990
70 Added 3.1%
2,326 $289,000
Q1 2019

May 01, 2019

BUY
$81.56 - $100.67 $183,999 - $227,111
2,256 New
2,256 $227,000
Q3 2017

Nov 07, 2017

SELL
$59.73 - $65.4 $112,172 - $122,821
-1,878 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
1,878
1,878 $117,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Harfst & Associates, Inc. Portfolio

Follow Harfst & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harfst & Associates, Inc. with notifications on news.